- Fin de la CAM au métro Longueuil: Une décision odieuse, selon Transport 2000 – http://bit.ly/98tYbh #
- Longueuil: les usagers du métro devraient passer à la TRAM 3 – http://bit.ly/d75V7k #
- Le Bixi s’exporte aux États-Unis et en Australie – http://bit.ly/diVYfX #
- How to share work more effectively, http://ow.ly/138BT #
- Innovation doesn't have to be eye-catching, http://ow.ly/138Cw #
- Why your brain likes to take it easy, http://ow.ly/13AdZ #
- Pfizer aims to reduce R&D spending by as much as $3 billion, http://ow.ly/14NOj #
- Study links gene deletions to morbid obesity, http://ow.ly/14NOG #
- Scientists find areas in human genome responsible for gene regulation, http://ow.ly/14NOY #
- Japanese researchers identify 25 potential targets for leukemia drugs, http://ow.ly/14NPh #
- Abbott might acquire more companies this year, CEO says, http://ow.ly/14NPI #
- Vertex reports positive data from trial of cystic fibrosis drug, http://ow.ly/14NQ6 #
- GSK buys exclusive rights to Apeiron's lung disease drug, http://ow.ly/14NQz #
- RT @biotechmontreal: Semaine prochaine / Next week: 2010-02-16 – Baldwin Barmacie – RSVP: info@biotechmontreal.ca ou/or http://ow.ly/154Ta #
